05:58

What are the current frontline immunotherapy choices for patients with advanced disease?

04:57

What is staging and what are the different stages of lung cancer?

03:43

What is next generation sequencing and who should get it?

02:15

What is the best initial treatment for hormone receptor positive cancer with spread to other organs?

06:29

Who are the best candidates for risk-reducing mastectomy?

06:44

If N1mi disease is found with SLNB during upfront surgery, is further axillary surgery needed?

06:00

Can you omit ALND if ACOSOG 1071 criteria is met and sentinel lymph nodes negative intraoperatively?

07:09

When performing a contralateral prophylactic mastectomy, do you perform a SLNB? How do you decide?

04:42

Are you less likely to recommend post mastectomy radiation therapy in HER2+ disease than in TNBC?

03:53

What is Ki67 and how is it used in treatment decision making?

04:11

What is a CDK 4/6 inhibitor?

03:30

How is targeted therapy used in hormone receptor positive breast cancer?

04:20

What are the key management strategies to prevent and/or reduce alpelisib-related toxicities?

03:28

How is HER2 status determined?

02:36

What is next generation sequencing and why is it important?

02:41

Describe the use of genomics to predict the benefit of radiation in ER+ breast cancer

04:45

What is the difference between somatic and germline abnormalities?

04:31

What are quantum dots? Explain their significance in breast cancer treatment

05:17

Patient Success Stories: HER2+ Metastatic Breast Cancer, Mark Pegram MD

03:41

What is MSI high and what does it mean in breast cancer?

03:59

What is NTRK? Do we have any drugs for patients with this alteration?

05:14

What is PIK3CA? Do we have drugs for patients with this alteration?

06:41

What are PARP inhibitors and where do we use them in breast cancer?

10:45

What are the current screening guidelines for breast cancer?

08:18

What scenarios warrant a breast ultrasound?

05:51

Does menopausal hormone therapy increase breast cancer risk?

11:00

How do you approach localized breast cancer during pregnancy?

06:02

Which ER+ HER2- patients with operable stage II or III disease should receive preoperative therapy?

04:07

What are the various approaches to treat brain metastases?

07:02

How can patients improve their quality of life while receiving endocrine therapy for breast cancer?

03:58

What is nipple sparing mastectomy?

02:22

I have sickle cell anemia. Will this affect chemotherapy for breast cancer?

04:28

What is hypofractionation and when is it indicated in early-stage breast cancer?

06:21

What are the risks for receiving gadolinium-based contrast agents?

04:10

What is staging and what are the different stages of breast cancer?

05:52

How do you treat Stage 3 lung cancer?

04:40

When is the best time to start durvalumab after chemoradiation? When is treatment response assessed?

08:33

What are the differences between a regular mammogram and tomosynthesis?

02:16

When performing a contralateral prophylactic mastectomy, is sentinel lymph node biopsy done (SLNB)?

02:31

Why is a boost delivered to the chest wall scar after mastectomy?

03:07

What is the role radiation therapy in controlling leptomeningeal disease?

04:02

What is short course whole breast radiation? What makes me a good candidate for this?

03:27

What is SBRT and when do you use it in your patients?

03:27

What is oligometastatic disease and when do you treat it?

03:59

What is brachytherapy?

03:54

What is a breath hold technique and why is it used?

03:06

What is a bolus and when is it used in radiation treatments?

06:05

What are the indications to treat with radiation therapy after mastectomy?

03:05

Patient Success Stories: Localized HER2+ Breast Cancer, Frank Vicini MD

04:27

Is there a role for proton beam therapy in breast cancer?

05:19

In N1 cancer with pathologic PR/CR after neoadjuvant chemotherapy, how is radiation involved?

03:19

If I undergo a lumpectomy, do I need to have radiation therapy?

02:36

I have N1mi disease. Do I need radiation therapy to my lymph nodes?

03:40

How does radiation therapy (RT) affect breast implants?

03:12

Are radiation treatments delivered differently for obese patients?

04:46

Who is a candidate for IORT?

02:44

When is lymphedema surveillance recommended? When are prophylactic lymphedema measures considered?

01:16

What should I look for when selecting a radiation oncologist?

03:15

Patient Success Stories: Metastatic Pancreatic Cancer, Michael Pishvaian MD

03:30

What partial breast regimens are appropriate?